Literature DB >> 28853400

Susceptibility to exacerbation in COPD.

John R Hurst1, Antonio Anzueto2, Jørgen Vestbo3.   

Abstract

Mesh：

Year:  2017        PMID： 28853400     DOI： 10.1016/S2213-2600(17)30307-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

Review 1.  A time for everything and everything in its time - exploring the mechanisms underlying seasonality of COPD exacerbations.

Authors:  Alexander Hicks; Eugene Healy; Natasha Sandeman; Martin Feelisch; Tom Wilkinson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-05

2.  The Heterogeneity of COPD Patients in a Community-Based Practice and the Inadequacy of the Global Initiative for Chronic Obstructive Lung Disease Criteria: A Real-World Experience.

Authors:  Fortune O Alabi; Hadaya A Alkhateeb; Kayla M DeBarros; Pierina S Barletti Benel; Rachel L Sanchez-Martez; Mia L Zeper; Reema A Ismail; Fred Umeh; Nelson Medina-Villanueva
Journal:  Chronic Obstr Pulm Dis       Date:  2021-07-28

3.  Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection.

Authors:  Ariadna Fernández-Calvet; Begoña Euba; Celia Gil-Campillo; Arancha Catalan-Moreno; Javier Moleres; Sara Martí; Alexandra Merlos; Jeroen D Langereis; Francisco García-Del Portillo; Lauren O Bakaletz; Garth D Ehrlich; Eric A Porsch; Margarita Menéndez; Joshua C Mell; Alejandro Toledo-Arana; Junkal Garmendia
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

4.  Reply to Polverino: Cigarette Smoking and COVID-19: A Complex Interaction.

Authors:  Guoshuai Cai; Yohan Bossé; Feifei Xiao; Farrah Kheradmand; Christopher I Amos
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

5.  From GOLD 0 to Pre-COPD.

Authors:  MeiLan K Han; Alvar Agusti; Bartolome R Celli; Gerard J Criner; David M G Halpin; Nicolas Roche; Alberto Papi; Robert A Stockley; Jadwiga Wedzicha; Claus F Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2021-02-15       Impact factor: 21.405
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.